SKYE Skye Bioscience, Inc.: institutional ownership and insider trading
40 funds reported holding $11.9M of Skye Bioscience, Inc. in their latest 13F filings; in Q2 2026 funds net sold $56.7K, with 6 new positions and 3 funds selling out; over the last 12 months insiders bought $0 and sold $889K on the open market.
Famous investors holding SKYE
- Izzy Englander (Millennium Management): $138K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $86.0K, 0.0% of the portfolio
Largest institutional holders of SKYE
- 5AM Venture Management, LLC — $6.71M
- Versant Venture Management, LLC — $1.39M
- BAKER BROS. ADVISORS LP — $1.09M
- VANGUARD GROUP INC — $662K
- VANGUARD CAPITAL MANAGEMENT LLC — $529K
- SPHERA FUNDS MANAGEMENT LTD. — $471K
- PLATINUM INVESTMENT MANAGEMENT LTD — $162K
- BlackRock, Inc. (BLK) — $161K
- GEODE CAPITAL MANAGEMENT, LLC — $151K
- MILLENNIUM MANAGEMENT LLC — $138K
Recent SKYE insider trades
- Sep 23, 2026: Rocklage Scott M sold 148,079 shares ($240K)
- Sep 23, 2026: Schwab Andrew J. sold 148,079 shares ($240K)
- Sep 16, 2026: Rocklage Scott M sold 33,892 shares ($64.7K)
- Sep 16, 2026: Schwab Andrew J. sold 33,892 shares ($64.7K)
5%+ owners
- Andrew J. Schwab: 30.2% (Schedule 13D/A, filed Aug 18, 2026)